Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.785 USD | +2.57% | +11.32% | -1.43% |
14/05 | Transcript : Acumen Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
08/05 | Acumen Pharmaceuticals Doses 1st Patient in Alzheimer's Disease Drug Study | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.43% | 22Cr | |
+29.48% | 4.92TCr | |
+0.77% | 4.21TCr | |
+50.47% | 4.04TCr | |
-5.26% | 2.89TCr | |
+13.54% | 2.61TCr | |
-22.73% | 1.87TCr | |
+8.31% | 1.33TCr | |
+32.61% | 1.23TCr | |
-1.06% | 1.2TCr |
- Stock Market
- Equities
- ABOS Stock
- News Acumen Pharmaceuticals, Inc.
- Acumen Pharmaceuticals Prices Upsized $130 Million Common Stock Offering